News

 

---

FOR IMMEDIATE RELEASE

Contact:
Neurorepair, Inc.
Corporate Communications
18484 Calle La Serra
Rancho Santa Fe, Ca 92091

Neurorepair, Inc., a privately held company, today announced that Dr. Jay Short and Dr. Steven Potkin Short have joined the company's scientific advisory board.

Rancho Santa Fe, CA --March 15, 2007 -- Dr. Jay Short is well-known for global protein evolution and engineering services and has authored more than 100 publications and is named inventor of over 100 issued patents and several hundred pending patents.

He has served on the U.S. National Research Council panel for Chemical Science and Technology at the National Institute of Standards and Technology and numerous other governmental, grant and journal review committees and boards.

Dr. Short is currently the President and Chairman of the E.O. Wilson Biodiversity Foundation with offices in San Diego, CA and Cambridge, MA.

He also currently serves on the Boards of Directors of Invitrogen, a biotechnology company in the area of gene expression, Senomyx, a leader in using biotechnology for the development of novel food and beverage ingredients; Anaptys, a second-generation therapeutic antibody company; and is Entrepreneur in Residence for UCSD-Connect. Dr. Short joined the Neurorepair SAB in March, 2007.

Steven G. Potkin, MD, has been a Professor in the Department of Psychiatry and Human Behavior at the University of California, Irvine (UCI) for the past 15 years. Dr. Potkin received his medical degree from Washington University in St. Louis. Trained as a psychiatrist at Duke University, Dr. Potkin spent nine years at the National Institutes of Mental Health (NIMH) as a clinical research psychiatrist before coming to UCI in 1985. Dr. Potkin’s career has been devoted to understanding the causes of, and developing new treatments for, schizophrenia. Dr. Potkin’s scientific work has established that schizophrenia is a biological illness. In addition to his academic appointment at UCI, Dr. Potkin has served for the past 14 years as the Director of Clinical Research at the UCI Neuropsychiatric Center and the Robert R. Sprague Director of the UCI Brain Imaging Center for the past few years.

For additional information contact: info@neurorepair.com

# # #

---

FOR IMMEDIATE RELEASE

Contact:
Neurorepair, Inc.
Corporate Communications
18484 Calle La Serra
Rancho Santa Fe, Ca 92091

Dr. Frank Eekman moves on to launch The Centient Biotech Investor e-newsletter.

Rancho Santa Fe, CA --November 30, 2006 -- Dr. Frank Eeckman has left Neurorepair to concentrate on his biotech consultancy practice and on his e-newsletter The Centient Biotech Investor. CEO Matthew Klipstein will take on the responsibilities formerly held by the Company’s President.

For additional information contact: info@neurorepair.com

# # #